BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 22788994)

  • 1. Update on carbonic anhydrase inhibitors: a patent review (2008 - 2011).
    Aggarwal M; McKenna R
    Expert Opin Ther Pat; 2012 Aug; 22(8):903-15. PubMed ID: 22788994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Indanesulfonamides as carbonic anhydrase inhibitors. Toward structure-based design of selective inhibitors of the tumor-associated isozyme CA IX.
    Thiry A; Ledecq M; Cecchi A; Dogné JM; Wouters J; Supuran CT; Masereel B
    J Med Chem; 2006 May; 49(9):2743-9. PubMed ID: 16640335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Designing of novel carbonic anhydrase inhibitors and activators.
    Supuran CT; Vullo D; Manole G; Casini A; Scozzafava A
    Curr Med Chem Cardiovasc Hematol Agents; 2004 Jan; 2(1):49-68. PubMed ID: 15328829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carbonic anhydrases: novel therapeutic applications for inhibitors and activators.
    Supuran CT
    Nat Rev Drug Discov; 2008 Feb; 7(2):168-81. PubMed ID: 18167490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carbonic anhydrase inhibitors: an editorial.
    Supuran CT
    Expert Opin Ther Pat; 2013; 23(6):677-9. PubMed ID: 23461558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carbonic anhydrases as targets for medicinal chemistry.
    Supuran CT; Scozzafava A
    Bioorg Med Chem; 2007 Jul; 15(13):4336-50. PubMed ID: 17475500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anticonvulsant/antiepileptic carbonic anhydrase inhibitors: a patent review.
    Aggarwal M; Kondeti B; McKenna R
    Expert Opin Ther Pat; 2013; 23(6):717-24. PubMed ID: 23514045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carbonic anhydrase inhibitors: a review on the progress of patent literature (2011-2016).
    Lomelino C; McKenna R
    Expert Opin Ther Pat; 2016 Aug; 26(8):947-56. PubMed ID: 27387065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carbonic anhydrase inhibition as a cancer therapy: a review of patent literature, 2007 - 2009.
    Poulsen SA
    Expert Opin Ther Pat; 2010 Jun; 20(6):795-806. PubMed ID: 20476848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kinetic and in silico analysis of thiazolidin-based inhibitors of α-carbonic anhydrase isoenzymes.
    Ekinci D; Fidan İ; Durdagi S; Kaban Ş; Supuran CT
    J Enzyme Inhib Med Chem; 2013 Apr; 28(2):370-4. PubMed ID: 23173744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carbonic anhydrase inhibitors as antitumor/antimetastatic agents: a patent review (2008-2018).
    Nocentini A; Supuran CT
    Expert Opin Ther Pat; 2018 Oct; 28(10):729-740. PubMed ID: 30074415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carbonic anhydrase inhibitors and activators for novel therapeutic applications.
    Supuran CT
    Future Med Chem; 2011 Jul; 3(9):1165-80. PubMed ID: 21806379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carbonic anhydrase inhibitors.
    Supuran CT
    Bioorg Med Chem Lett; 2010 Jun; 20(12):3467-74. PubMed ID: 20529676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carbonic anhydrase inhibitors: inhibition of human cytosolic isozymes I and II and tumor-associated isozymes IX and XII with S-substituted 4-chloro-2-mercapto-5-methyl-benzenesulfonamides.
    Saczewski F; Innocenti A; Sławiński J; Kornicka A; Brzozowski Z; Pomarnacka E; Scozzafava A; Temperini C; Supuran CT
    Bioorg Med Chem; 2008 Apr; 16(7):3933-40. PubMed ID: 18242998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure, function and applications of carbonic anhydrase isozymes.
    Imtaiyaz Hassan M; Shajee B; Waheed A; Ahmad F; Sly WS
    Bioorg Med Chem; 2013 Mar; 21(6):1570-82. PubMed ID: 22607884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiglaucoma carbonic anhydrase inhibitors: a patent review.
    Masini E; Carta F; Scozzafava A; Supuran CT
    Expert Opin Ther Pat; 2013; 23(6):705-16. PubMed ID: 23627893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure-based drug discovery of carbonic anhydrase inhibitors.
    Supuran CT
    J Enzyme Inhib Med Chem; 2012 Dec; 27(6):759-72. PubMed ID: 22468747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carbonic anhydrase IX: a new druggable target for the design of antitumor agents.
    Winum JY; Rami M; Scozzafava A; Montero JL; Supuran C
    Med Res Rev; 2008 May; 28(3):445-63. PubMed ID: 17880011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diuretics with carbonic anhydrase inhibitory action: a patent and literature review (2005 - 2013).
    Carta F; Supuran CT
    Expert Opin Ther Pat; 2013; 23(6):681-91. PubMed ID: 23488823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic applications of glycosidic carbonic anhydrase inhibitors.
    Winum JY; Poulsen SA; Supuran CT
    Med Res Rev; 2009 May; 29(3):419-35. PubMed ID: 19058143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.